CHLAMYDIA IN-OFFICE RAPID DIAGNOSTIC ASSAYS
This article was originally published in The Gray Sheet
Executive Summary
CHLAMYDIA IN-OFFICE RAPID DIAGNOSTIC ASSAYS lack sufficient sensitivity to ensure treatment of asymptomatic women with Chlamydia infections, Edward Book, MD, University of Alabama Department of Medicine, Birmingham, et al. conclude in a study published in the Sept. 21 Journal of the American Medical Association. Noting the 48.5% sensitivity rate seen with the rapid Chlamydia assay in the study, the authors point out that the rapid test, "had it been used exclusively for Chlamydia screening, would have resulted in treatment for less than half of all women with culture-proven infections."
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.